12.15
前日終値:
$16.44
開ける:
$12
24時間の取引高:
2.90M
Relative Volume:
11.62
時価総額:
$148.90M
収益:
$1.54M
当期純損益:
$-38.70M
株価収益率:
-2.6017
EPS:
-4.67
ネットキャッシュフロー:
$-36.86M
1週間 パフォーマンス:
-28.02%
1か月 パフォーマンス:
-3.95%
6か月 パフォーマンス:
+62.65%
1年 パフォーマンス:
-23.87%
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
名前
Corbus Pharmaceuticals Holdings Inc
セクター
電話
617-963-0103
住所
500 RIVER RIDGE DRIVE, NORWOOD, MA
CRBP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
12.15 | 201.48M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | 再開されました | B. Riley Securities | Buy |
| 2025-02-28 | 開始されました | William Blair | Outperform |
| 2024-12-02 | 開始されました | Piper Sandler | Overweight |
| 2024-07-30 | 開始されました | Wedbush | Outperform |
| 2024-07-22 | 再開されました | H.C. Wainwright | Buy |
| 2024-06-26 | 開始されました | B. Riley Securities | Buy |
| 2024-06-03 | 繰り返されました | Oppenheimer | Outperform |
| 2024-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-03-06 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-08 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-09-08 | ダウングレード | Jefferies | Buy → Hold |
| 2020-09-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-07-07 | 開始されました | ROTH Capital | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-03-26 | 開始されました | Nomura | Buy |
| 2019-04-05 | 開始されました | Jefferies | Buy |
| 2019-03-20 | 開始されました | Oppenheimer | Outperform |
| 2019-01-11 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-12-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2018-10-24 | 開始されました | B. Riley FBR | Buy |
| 2018-01-19 | 開始されました | Raymond James | Outperform |
| 2017-12-14 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-11-08 | 繰り返されました | Noble Financial | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-03-30 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2016-11-11 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース
Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetQuarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Published on: 2025-11-02 11:47:57 - newser.com
Published on: 2025-11-02 07:07:31 - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.Trade Entry Summary & High Conviction Buy Zone Picks - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movement2025 Stock Rankings & Daily Stock Momentum Reports - newser.com
Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsMarket Growth Report & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 11:30:29 - newser.com
Published on: 2025-11-01 08:40:29 - newser.com
Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing By Investing.com - Investing.com Australia
Published on: 2025-11-01 04:04:11 - newser.com
Corbus prices $75 million public offering of common stock By Investing.com - Investing.com Philippines
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) - Seeking Alpha
Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com - Investing.com UK
Corbus Pharmaceuticals stock plunges after $75 million public offering - Investing.com India
Corbus Pharmaceuticals announces common stock offering By Investing.com - Investing.com Australia
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. losses2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-31 05:15:03 - newser.com
Published on: 2025-10-31 05:14:27 - newser.com
Corbus Pharmaceuticals Prices $75 Million Offering; Shares Down Pre-Bell - MarketScreener
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsMarket Risk Summary & Fast Gain Swing Alerts - newser.com
Corbus prices $75 million public offering of common stock - Investing.com
How Corbus Pharmaceuticals Holdings Inc. (3371) stock compares with market leaders2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Corbus Pharmaceuticals Announces Pricing of Public Offering - The Manila Times
Corbus Pharmaceuticals announces pricing of public offering at $13.00 per share - MarketScreener
Corbus Pharma (Nasdaq: CRBP) prices $75M offering with pre-funded warrants, 30-day option - Stock Titan
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarJuly 2025 Momentum & Daily Profit Focused Screening - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock vulnerable to regulatory risksTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Corbus Pharmaceuticals announces common stock offering - Investing.com
CRBP Plans New Offering Managed by Jefferies and Piper Sandler - GuruFocus
Corbus Pharmaceuticals (CRBP) announces Public Offering to Fund Development - GuruFocus
Corbus Pharmaceuticals announces proposed public offering - MarketScreener
Corbus Pharmaceuticals Announces Preliminary Q3 Financials - TipRanks
Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing - Investing.com
Corbus Pharmaceuticals Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Corbus Pharmaceuticals Announces Proposed Public Offering - The Manila Times
Corbus Pharma (NASDAQ: CRBP) to offer common stock, pre-funded warrants; 15% option - Stock Titan
Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyTrade Ideas & Intraday High Probability Setup Alerts - newser.com
Corbus Pharmaceuticals Holdings Inc (CRBP) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):